- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about GILD
Recent news which mentions GILD
This Analyst Downgrades Bristol-Myers Squibb, Cautions Amid Product Launch And Revenue Concerns
January 03, 2024
From Benzinga
Nasdaq 100 Alert: 7 Undervalued Tech Stocks Ready to Rocket in 2024
January 03, 2024
From InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
January 02, 2024
From Benzinga
The 500 Top Stocks to Buy for 2024, Ranked by AI
December 29, 2023
From InvestorPlace
$100 Invested In This Stock 20 Years Ago Would Be Worth $1,100 Today
December 25, 2023
From Benzinga
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
December 22, 2023
From Benzinga
A Look Into Gilead Sciences Inc's Price Over Earnings
December 22, 2023
From Benzinga
3 Biotech Stocks to Buy in the TradeSmith ‘Green Zone’
December 21, 2023
From InvestorPlace
Why Is Immunotherapy-Focused Hookipa Pharma Stock Soaring Today?
December 21, 2023
From Benzinga
Why Is Hookipa Pharma (HOOK) Stock Up 81% Today?
December 21, 2023
From InvestorPlace
RedHill's Investigational COVID-19 Drugs Combined With Gilead's Show Effect Against Ebola
December 20, 2023
From Benzinga
From Benzinga
Why Is Compugen (CGEN) Stock Up 189% Today?
December 19, 2023
From InvestorPlace
Patients Regain Weight After They Quit Using Ozempic Rival Zepbound. Here's Why That Makes Eli Lilly Stock an Even Better Buy.
December 16, 2023
From Motley Fool
Pharma’s Frontline: 3 Stocks Driving Revolutionary Drug Development
December 15, 2023
From InvestorPlace
A Bull Market Is Coming: 1 Stock That Could Rocket 219% Higher in 2024, According to Wall Street
December 12, 2023
From Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
December 11, 2023
From Benzinga
Gilead Sciences Battles Rising Threat of Drug Counterfeiting, Initiates Legal Actions
December 11, 2023
From Benzinga
This 1 Emerging Risk Could Be a Problem for These 3 Big Pharma Stocks
December 10, 2023
From Motley Fool
Next-Gen Biotech: 3 Companies Leading the Charge in Gene Therapy
December 07, 2023
From InvestorPlace
3 Biotech Stocks That Could Be Multibaggers in the Making
November 30, 2023
From InvestorPlace
2 Biotech Stocks You Can Buy and Hold for the Next Decade
November 30, 2023
From Motley Fool
Eyes On Novartis, Gilead, Bristol Myers As FDA Weighs Risks Vs. Benefits Of Approved CAR T-Cell Therapies
November 29, 2023
From Benzinga
Cabaletta Bio’s and Gracell’s stock falls sharply as FDA investigates risks of CAR-T therapy
November 28, 2023
From MarketWatch
3 Fantastic Dividend Stocks to Buy Sooner Rather Than Later
November 26, 2023
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.